The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare professionals about the risk of a drug-drug interaction (DDI) associated with concomitant use of warfarin and tramadol. Taking these two medicines simultaneously can lead to an increase in the International Normalised Ratio...
The South African Health Products Regulatory Authority (SAHPRA) hosted a webinar to launch the NDS (National Drug Control System) Applications Portal – for import and export applications, specifically for Narcotics and Controlled Substances only. What was covered? How does the portal work How to submit your...
The South African Health Products Regulatory Authority (SAHPRA) recently hosted its Regulatory Technical Forum (RTF) Meeting, which brought together key industry stakeholders to discuss regulatory updates. Areas of discussion on the agenda included: Medicines (Allopathic) Clinical Updates Veterinary Medicines Complementary Medicines Inspectorate and Regulatory Compliance Medical...
The South African Health Products Regulatory Authority (SAHPRA) hosted a webinar to provide Industry with updates on the recently launched Engagement Portal. Why should you attend? SAHPRA will provide updates on: SAHPRA Portal roll-out Discuss the activities for the remainder of May and staggered activation of: ...
The South African Health Products Regulatory Authority (SAHPRA) is hosting an Emergency Webinar to address numerous Section 21 technical queries regarding the registration of organisations/ applicants and the submission of applications. This webinar session aims to focus on the submission of Section 21 applications for Category...
The South African Health Products Regulatory Authority (SAHPRA) has become aware of processing issues after the launch of the SAHPRA Engagement Portal on 01 April 2025. This webinar aims to address processing issues around system failures. Applicants are encouraged to attend to address issues regarding: Assistance and...
The South African Health Products Regulatory Authority (SAHPRA) has become aware of processing issues after the launch of the SAHPRA Engagement Portal on 01 April 2025. This webinar aims to address processing issues around system failures. Applicants are encouraged to attend to address issues regarding: Assistance and...
The South African Health Products Regulatory Authority (SAHPRA) became aware of processing issues after the launch of the SAHPRA Engagement Portal on 01 April 2025. This webinar aimed to address processing issues around system failures. Applicants are encouraged to attend to address issues regarding: Assistance and guidance...
Pretoria, 04 April 2025 –The South African Health Products Regulatory Authority (SAHPRA) has joined the Medical Device Single Audit Programme (MDSAP), an international audit programme of medicines and medical device regulators aimed at improving efficiencies in the regulation of medical device manufacturers by engaging in work...
Pretoria, 24 March 2025 –The South African Health Products Regulatory Authority (SAHPRA), in partnership with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of the Witwatersrand, proudly announces the graduation of the fourth cohort from the Clinical Assessors Short Course —...
